How big is Lisata Therapeutics, Inc.?

Jun 22 2025 06:32 PM IST
share
Share Via
As of Jun 18, Lisata Therapeutics, Inc. has a market capitalization of 20.66 million, with net sales of 1.00 million and a net loss of 19.30 million over the latest four quarters. Shareholder's funds are valued at 29.57 million, and total assets amount to 35.00 million.
As of Jun 18, Lisata Therapeutics, Inc. has a market capitalization of 20.66 million, categorizing it as a Micro Cap company.

As of Jun 18, the company reported net sales of 1.00 million for the latest four quarters, while the net profit for the same period was a loss of 19.30 million.

As of Dec 24, the shareholder's funds were valued at 29.57 million, and the total assets amounted to 35.00 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Lisata Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:38 AM IST
share
Share Via
What does Lisata Therapeutics, Inc. do?
Jun 22 2025 07:22 PM IST
share
Share Via